A01=Nicole Hassoun
Age Group_Uncategorized
Age Group_Uncategorized
Author_Nicole Hassoun
automatic-update
Category1=Non-Fiction
Category=HP
Category=HPQ
Category=JKSR
Category=JP
Category=PSAD
Category=QD
Category=QDTQ
COP=United States
Delivery_Delivery within 10-20 working days
eq_bestseller
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
eq_society-politics
Language_English
PA=Available
Price_€20 to €50
PS=Active
softlaunch
Product details
- ISBN 9780197514993
- Weight: 635g
- Dimensions: 236 x 163mm
- Publication Date: 17 Sep 2020
- Publisher: Oxford University Press Inc
- Publication City/Country: US
- Product Form: Hardback
- Language: English
Secure
checkout
Fast Shipping
Easy returns
Every year nine million people are diagnosed with tuberculosis, every day over 13,400 people are infected with AIDs, and every thirty seconds malaria kills a child. For most of the world, critical medications that treat these deadly diseases are scarce, costly, and growing obsolete, as access to first-line drugs remains out of reach and resistance rates rise. Rather than focusing research and development on creating affordable medicines for these deadly global diseases, pharmaceutical companies instead invest in commercially lucrative products for more affluent customers.
Nicole Hassoun argues that everyone has a human right to health and to access to essential medicines, and she proposes the Global Health Impact (global-health-impact.org/new) system as a means to guarantee those rights. Her proposal directly addresses the pharmaceutical industry's role: it rates pharmaceutical companies based on their medicines' impact on improving global health, rewarding highly-rated medicines with a Global Health Impact label.
Global Health Impact has three parts. The first makes the case for a human right to health and specifically access to essential medicines. Hassoun defends the argument against recent criticism of these proposed rights. The second section develops the Global Health Impact proposal in detail. The final section explores the proposal's potential applications and effects, considering the empirical evidence that supports it and comparing it to similar ethical labels. Through a thoughtful and interdisciplinary approach to creating new labeling, investment, and licensing strategies, Global Health Impact demands an unwavering commitment to global justice and corporate responsibility.
Nicole Hassoun is Professor of Philosophy at Binghamton University and Visiting Scholar at Cornell University. She co-directs the Institute for Justice and Well-Being and is affiliated with the University of Pittsburgh's Center for Bioethics and Health Law. She is the author of Globalization and Global Justice (Cambridge University Press 2012), and has published widely in journals including American Philosophical Quarterly, Journal of Development Economics, PLoS One, The European Journal of Philosophy, American Journal of Tropical Medicine and Hygiene, and The Australasian Journal of Philosophy.
